Cited by 5,141Research on Leishmaniasis StudiesLeprosy Research and TreatmentBrucella: diagnosis, epidemiology, treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Open access

Alvar, Jorge, Vélez, Iván D., Bern, Caryn, Herrero, Mercé, Desjeux, Philippe, Cano, Jorge, Jannin, Jean, Boer, Margriet den, the WHO Leishmaniasis Control Team·2012·PLoS ONE

DOI 10.1371/journal.pone.0035671PMC PMC3365071

Open this paper in CoChat — free account Open PDF

Abstract

As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035671

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
Background
World Development Report 1993
Bank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
Background
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
Background
Leishmaniasis and poverty
Alvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
Background
Leishmaniasis
Desjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
Background
Control Of The Leishmaniases
Library, W. (2010) · Cited by 584

Flagged first, then by citations

Show all 51 references

Research works printed but not linked: 1

AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931

Sorted by citations

Items 201–300 of 1,004

Leishmanioses cutanées
Mokni, M. (2019) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2019.02.002 · Cited by 97
DDT-based indoor residual spraying suboptimal for visceral leishmaniasis elimination in India
Coleman, M. M., Foster, G. M., Deb, R. M., Singh, R. P., Ismail, H. M., Shivam, P., Ghosh, A. K., Dunkley, S., Kumar, V., Coleman, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507782112 · Cited by 96
Antileishmanial activity and cytotoxicity of Brazilian plants
Ribeiro, T. G., Chávez‐Fumagalli, M. Á., Valadares, D. G., Franca, J. R., Lage, P. S., Duarte, M. C., Andrade, P. H. R., Martins, V. T., Costa, L. E., de Arruda, A. L. A., et al. (2014) · Experimental Parasitology · doi:10.1016/j.exppara.2014.05.004 · Cited by 96
The balancing act: Immunology of leishmaniosis
Toepp, A. J., & Petersen, C. A. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.02.004 · Cited by 94
Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA
Ceccarelli, M., Galluzzi, L., Migliazzo, A., & Magnani, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088845 · Cited by 96
Identification of phlebotomine sand flies using one MALDI-TOF MS reference database and two mass spectrometer systems
Mathis, A., Depaquit, J., Dvořák, V., Tuten, H. C., Bañuls, A., Halada, P., Zapata, S., Lehrter, V., Hlavačková, K., Prudhomme, J., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0878-2 · Cited by 95
Spatial Distribution of Sand Fly Vectors and Eco-Epidemiology of Cutaneous Leishmaniasis Transmission in Colombia
Ferro, C., López, M., Fuya, P., Lugo, L., Cordovez, J. M., & González, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139391 · Cited by 95
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission
White, S. L., Rawlinson, W. D., Boan, P., Sheppeard, V. K., Wong, G., Waller, K. M. J., Opdam, H. I., Kaldor, J. M., Fink, M. A., Verran, D. J., et al. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000852 · Cited by 99
The immunology of Leishmania/HIV co-infection
Okwor, I., & Uzonna, J. E. (2013) · Immunologic Research · doi:10.1007/s12026-013-8389-8 · Cited by 95
Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets
Ogungbe, I. V., Erwin, W. R., & Setzer, W. N. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.12.010 · Cited by 95
New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment
Chávez‐Fumagalli, M. Á., Ribeiro, T. G., Castilho, R. O., Fernandes, S. O. A., Cardoso, V. N., Coelho, C. S. P., Mendonça, D. V. C., Soto, M., Tavares, C. A. P., Faraco, A. A. G., et al. (2015) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0138-2015 · Cited by 94
Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016
Bezerra, J. M. T., de Araújo, V. E. M., Barbosa, D. S., Martins‐Melo, F. R., Werneck, G. L., & Carneiro, M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006697 · Cited by 94
The intriguing host innate immune response: novel anti-parasitic defence by neutrophil extracellular traps
Hermosilla, C. R., MuĂąoz-Caro, T., Silva, L. M. R., Ruíz, A., & Taubert, A. (2014) · Parasitology · doi:10.1017/s0031182014000316 · Cited by 96
Molecular diagnosis of cutaneous leishmaniasis and identification of the causative Leishmania species in Morocco by using three PCR-based assays
Mouttaki, T., Morales‐Yuste, M., Merino-Espinosa, G., Chiheb, S., Fellah, H., Martín‐Sánchez, J., & Riyad, M. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-420 · Cited by 94
Peptide Vaccines for Leishmaniasis
de Brito, R. C. F., Cardoso, J. M. D. O., Reis, L. E. S., Vieira, J. F. P., Mathias, F. A. S., Roatt, B. M., Aguiar‐Soares, R. D. D. O., Ruiz, J. C., Resende, D. D. M., & Reis, A. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01043 · Cited by 94
Neutrophil extracellular traps release induced by Leishmania : role of PI3Kγ, ERK, PI3Kσ, PKC, and [Ca2+]
DeSouza-Vieira, T. S., Guimarães-Costa, A. B., Rochael, N. C., de Lira, M. N., Nascimento, M. T. C., Lima-Gomes, P. D. S., Mariante, R. M., Persechini, P. M., & Saraiva, E. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0615-261rr · Cited by 95
Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014
dos Reis, L. L., Balieiro, A. A. D. S., Fonseca, F. R., & Gonçalves, M. J. F. (2017) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0243-2017 · Cited by 93
A decade bibliometric analysis of global research on leishmaniasis in Web of Science database
Soosaraei, M., Khasseh, A. A., Fakhar, M., & Hezarjaribi, H. Z. (2018) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2017.12.014 · Cited by 93
Risk Factors for Visceral Leishmaniasis among Residents and Migrants in Kafta-Humera, Ethiopia
Argaw, D., Mulugeta, A., Herrero, M., Nombela, N., Teklu, T., Tefera, T., Belew, Z., Alvar, J., & Bern, C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002543 · Cited by 93
Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines
Matrangolo, F. S. V., Liarte, D. B., Andrade, L. C., de Melo, M. F., Andrade, J. M., Fernandes-Ferreira, R., Santiago, A. D. S., Pirovani, C. P., da Silva-Pereira, R. A., & Murta, S. M. F. (2013) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2013.06.006 · Cited by 92
Therapeutic Options for Visceral Leishmaniasis
Monge‐Maíllo, B., & López‐Vélez, R. (2013) · Drugs · doi:10.1007/s40265-013-0133-0 · Cited by 92
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
Roatt, B. M., Aguiar‐Soares, R. D. D. O., Coura‐Vital, W., Ker, H. G., Moreira, N. D. D., Vitoriano-Souza, J., Giunchetti, R. C., Carneiro, C. M., & Reis, A. B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00272 · Cited by 92
Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
Wyllie, S., Roberts, A. J., Norval, S., Patterson, S., Foth, B. J., Berriman, M., Read, K. D., & Fairlamb, A. H. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005971 · Cited by 91
The effect of different parameters under ultrasound irradiation for synthesis of new nanostructured Fe3O4@bio-MOF as an efficient anti-leishmanial in vitro and in vivo conditions
Abazari, R., Mahjoub, A. R., Molaei, S., Ghaffarifar, F., Ghasemi, E., Slawin, A. M. Z., & Carpenter‐Warren, C. L. (2018) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2018.01.022 · Cited by 91
Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs
Kaye, P. M., Cruz, I., Picado, A., Bocxlaer, K. V., & Croft, S. L. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00788-y · Cited by 91
Risk map for cutaneous leishmaniasis in Ethiopia based on environmental factors as revealed by geographical information systems and statistics
Seid, A., Gadisa, E., Tsegaw, T., Abera, A., Teshome, A., Mulugeta, A., Herrero, M., Argaw, D., Jorge, A., Kebede, A., et al. (2014) · Geospatial health · doi:10.4081/gh.2014.27 · Cited by 91
Visceral leishmaniasis: host–parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host
Saporito, L., Giammanco, A., Grazia, S. D., & Colomba, C. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.12.024 · Cited by 91
Impacts of Climate Change on Vector Borne Diseases in the Mediterranean Basin — Implications for Preparedness and Adaptation Policy
Negev, M., Paz, S., Clermont, A., Pri-Or, N. G., Shalom, U., Yeger, T., & Green, M. S. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120606745 · Cited by 93
Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
Fiuza, J. A., Gannavaram, S., Santiago, H. C., Selvapandiyan, A., de Souza, D. M., Passos, L. S. A., de Mendonça, L. Z., Lemos-Giunchetti, D. D. S., Ricci, N. D., Bartholomeu, D. C., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.11.039 · Cited by 90
Arginine and Polyamines Fate in Leishmania Infection
Muxel, S. M., Aoki, J. I., Fernandes, J. C. R., Laranjeira‐Silva, M. F., Zampieri, R. A., Acuña, S. M., Müller, K. E., Vanderlinde, R. H., & Floeter‐Winter, L. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02682 · Cited by 92
Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases
Hollingsworth, T. D., Adams, E. R., Anderson, R. M., Atkins, K. E., Bartsch, S. M., Basáñez, M.-G., Behrend, M. R., Blok, D. J., Chapman, L. A. C., Coffeng, L. E., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1235-1 · Cited by 89
Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions
Dillon, L. A. L., Suresh, R., Okrah, K., Bravo, H. C., Mosser, D. M., & El-Sayed, N. M. (2015) · BMC Genomics · doi:10.1186/s12864-015-2237-2 · Cited by 88
The Global Burden of Disease of Zoonotic Parasitic Diseases: Top 5 Contenders for Priority Consideration
Pisarski, K. (2019) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed4010044 · Cited by 89
Cutaneous Leishmaniasis: The Complexity of Host’s Effective Immune Response against a Polymorphic Parasitic Disease
Gabriel, Á. M., Valério-Bolas, A., Palma-Marques, J., Mourata-Gonçalves, P., Ruas, P., Dias-Guerreiro, T., & Santos-Gomes, G. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/2603730 · Cited by 98
Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
Singh, O. P., & Sundar, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00296 · Cited by 89
Evaluation of Four Single-Locus Markers for Leishmania Species Discrimination by Sequencing
der Auwera, G. V., Ravel, C., Verweij, J. J., Bart, A., Schönian, G., & Felger, I. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02936-13 · Cited by 89
CanSergentomyia(Diptera, Psychodidae) play a role in the transmission of mammal-infectingLeishmania?
Maia, C., & Depaquit, J. (2016) · Parasite · doi:10.1051/parasite/2016062 · Cited by 89
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
Coelho, E. A. F., Ribeiro, T. G., Chávez‐Fumagalli, M. Á., Valadares, D. G., Franca, J. R., Rodrigues, L., Duarte, M., Lage, P. S., Andrade, P., Lage, D. P., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55678 · Cited by 88
Genetically Validated Drug Targets in Leishmania : Current Knowledge and Future Prospects
Jones, N. G., Catta‐Preta, C. M. C., Lima, A. P. C. A., & Mottram, J. C. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00244 · Cited by 88
Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence
Sundar, S., Singh, O. P., & Chakravarty, J. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1532790 · Cited by 88
Advancement in leishmaniasis diagnosis and therapeutics: An update
Kumari, D., Perveen, S., Sharma, R., & Singh, K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174436 · Cited by 92
Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
Madusanka, R. K., Silva, H., & Karunaweera, N. D. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00602-2 · Cited by 88
“At the global level, most annual cases occurred in western Asia, central Asia, the Americas and the Mediterranean basin [3].”
Background
Protective and Pathological Functions of CD8+T Cells in Leishmania braziliensis Infection
Cardoso, T. M., Machado, Á., Costa, D. L., Carvalho, L. P., Queiroz, A., Machado, P. R. L., Scott, P., Carvalho, E. M., & Bacellar, O. (2014) · Infection and Immunity · doi:10.1128/iai.02404-14 · Cited by 88
Evaluating drug resistance in visceral leishmaniasis: the challenges
Hendrickx, S., Guerin, P. J., Caljon, G., Croft, S. L., & Maes, L. J. R. M. (2016) · Parasitology · doi:10.1017/s0031182016002031 · Cited by 88
An interactive database of Leishmania species distribution in the Americas
Herrera, G., Barragán, N., Luna, N., Martínez, D., Martino, F. D., Medina, J. E., Niño, S., Páez, L., Ramírez, A., Vega, L., et al. (2020) · Scientific Data · doi:10.1038/s41597-020-0451-5 · Cited by 88
Fe3O4@piroctone olamine magnetic nanoparticles: Synthesize and therapeutic potential in cutaneous leishmaniasis
Albalawi, A. E., Khalaf, A. K., Alyousif, M. S., Alanazi, A. D., Baharvand, P., Shakibaie, M., & Mahmoudvand, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111566 · Cited by 87
Microorganisms and Climate Change: A Not so Invisible Effect
Ibáñez, A., Garrido-Chamorro, S., & Barreiro, C. (2023) · Microbiology Research · doi:10.3390/microbiolres14030064 · Cited by 99
Brazil's neglected tropical diseases: an overview and a report card
Hotez, P. J., & Fujiwara, R. T. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.07.006 · Cited by 86
Intrachromosomal Amplification, Locus Deletion and Point Mutation in the Aquaglyceroporin AQP1 Gene in Antimony Resistant Leishmania (Viannia) guyanensis
do Monte‐Neto, R. L., Laffitte, M.-C. N., Leprohon, P., dos Reis, P. G., Frézard, F., & Ouellette, M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003476 · Cited by 83
Differential Expression of miRNA Regulates T Cell Differentiation and Plasticity During Visceral Leishmaniasis Infection
Pandey, R. K., Sundar, S., & Prajapati, V. K. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00206 · Cited by 88
Essential oils: in vitro activity against Leishmania amazonensis, cytotoxicity and chemical composition
Andrade, M. A., Azevedo, C. D. S., Motta, F. N., dos Santos, M. L., Silva, C. L., Santana, J. M., & Bastos, I. M. D. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1401-9 · Cited by 86
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran
Bamorovat, M., Sharifi, I., Aflatoonian, M. R., Sharifi, H. P., Karamoozian, A., Sharifi, F., Khosravi, A., & Hassanzadeh, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192236 · Cited by 86
Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids
Coa, J. C., Castrillón-L, W., Cardona, W., Cardá, M., Ospina, V., Muñoz, J. A., Vélez, I. D., & Robledo, S. M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.018 · Cited by 87
Global Analysis of Protein N-Myristoylation and Exploration of N-Myristoyltransferase as a Drug Target in the Neglected Human Pathogen Leishmania donovani
Wright, M. H., Paape, D., Storck, E. M., Serwa, R. A., Smith, D. F., & Tate, E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.003 · Cited by 88
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
Patterson, S., Wyllie, S., Norval, S., Stojanovski, L., Simeons, F. R. C., Auer, J. L., Osuna‐Cabello, M., Read, K. D., & Fairlamb, A. H. (2016) · eLife · doi:10.7554/elife.09744 · Cited by 85
The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review
Pires, M., Wright, B., Kaye, P. M., da Conceição, V., & Churchill, R. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223313 · Cited by 85
Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response
Lecoeur, H., Prina, E., Rosazza, T., Kokou, K., N’Diaye, P., Aulner, N., Varet, H., Bussotti, G., Xing, Y., Milon, G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.030 · Cited by 93
Molecular systematics applied to Phlebotomine sandflies: Review and perspectives
Depaquit, J. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.10.027 · Cited by 85
Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species
Lockard, R. D., Wilson, M. E., & Rodríguez, N. E. (2019) · Journal of Immunology Research · doi:10.1155/2019/4103819 · Cited by 85
Leishmaniases in Greece
Ntais, P., Sifaki-Pistolla, D. I., Christodoulou, V., Messaritakis, I., Pratlong, F., Poupalos, G., & Antoniou, M. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0070 · Cited by 84
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review
Hirve, S. S., Boelaert, M., Matlashewski, G., Mondal, D., Arana, B. A., Kroeger, A., & Olliaro, P. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004896 · Cited by 84
Natural Products: Insights into Leishmaniasis Inflammatory Response
Rodrigues, I., Mazotto, A. M., Cardoso, V., Alves, R. L., Amaral, A., Silva, J. R. D. A., Pinheiro, A., & Vermelho, A. B. (2015) · Mediators of Inflammation · doi:10.1155/2015/835910 · Cited by 75
A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
Athanasiou, E., Agallou, M., Tastsoglou, S., Kammona, O., Hatzigeorgiou, A. G., Kiparissides, C. A., & Karagouni, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00684 · Cited by 84
A nationwide survey of Leishmania infantum infection in cats and associated risk factors in Italy
Iatta, R., Furlanello, T., Colella, V., Tarallo, V. D., Latrofa, M. S., Brianti, E., Trerotoli, P., Decaro, N., Lorusso, E., Schunack, B., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007594 · Cited by 83
Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World
Cosma, C., Maia, C., Khan, N., Infantino, M. G., & Riccio, M. D. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9110258 · Cited by 83
“In addition, the underreporting and underestimation of cases remain an open issue, well highlighted by studies suggesting that the actual number of infections may be a multiple of what is officially reported by health authorities [31].”
Innate immunity againstLeishmaniainfections
Gurung, P., & Kanneganti, T. (2015) · Cellular Microbiology · doi:10.1111/cmi.12484 · Cited by 83
Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
Guillon, J., Cohen, A., Gueddouda, N. M., Das, R. N., Moreau, S., Ronga, L., Savrimoutou, S., Basmaciyan, L., Monnier, A., Monget, M., et al. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1268608 · Cited by 83
Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for detection of Leishmania DNA in buffy coat from visceral leishmaniasis patients
Khan, M. G. M., Bhaskar, K. R. H., Salam, M. A., Akther, T., Pluschke, G., & Mondal, D. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-280 · Cited by 82
Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
Zahedifard, F., Gholami, E., Taheri, T., Taslimi, Y., Doustdari, F., Seyed, N., Torkashvand, F., Meneses, C., Papadopoulou, B., Kamhawi, S., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002751 · Cited by 82
Revising Leishmania’s life cycle
Bates, P. A. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0154-2 · Cited by 82
Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host
Klatt, S., Simpson, L., Maslov, D. A., & Konthur, Z. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007424 · Cited by 87
Mushrooms: an emerging resource for therapeutic terpenoids
Dasgupta, A., & Acharya, K. (2019) · 3 Biotech · doi:10.1007/s13205-019-1906-2 · Cited by 82
An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis
Cruz, I., Millet, A., Carrillo, E., Chenik, M., Salotra, P., Verma, S., Veland, N., Jara, M., Adaui, V., Castrillon, C. E., et al. (2013) · Experimental Parasitology · doi:10.1016/j.exppara.2013.03.026 · Cited by 82
Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective
Ferreira, L. L. G., & Andricopulo, A. D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.021 · Cited by 82
Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
Shadab, M., Jha, B., Asad, M., Deepthi, M., Kamran, M., & Ali, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171306 · Cited by 82
Leishmaniasis, conflict, and political terror: A spatio-temporal analysis
Berry, I., & Berrang‐Ford, L. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.04.038 · Cited by 81
Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum
Vakili, B., Eslami, M., Hatam, G., Zare, B., Erfani, N., Nezafat, N., & Ghasemi, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.125 · Cited by 81
Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012
Desjeux, P. M. P., Ghosh, R. S., Dhalaria, P., Wourgaft, N. S., & Zijlstra, E. E. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-196 · Cited by 81
Neglected tropical diseases in Central America and Panama: Review of their prevalence, populations at risk and impact on regional development
Hotez, P. J., Woc-Colburn, L. E., & Bottazzi, M. E. (2014) · International Journal for Parasitology · doi:10.1016/j.ijpara.2014.04.001 · Cited by 81
Molecular Identification and Polymorphism Determination of Cutaneous and Visceral Leishmaniasis Agents Isolated from Human and Animal Hosts in Iran
Hajjaran, H., Mohebali, M., Mamishi, S., Vasigheh, F., Oshaghi, M. A., Naddaf, S. R., Teimouri, A., Edrissian, G. H., & Zarei, Z. (2013) · BioMed Research International · doi:10.1155/2013/789326 · Cited by 80
The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis
Hartley, M., Drexler, S. K., Ronet, C., Beverley, S. M., & Fasel, N. J. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2014.05.006 · Cited by 81
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
Want, M. Y., Islamuddin, M., Chouhan, G., Ozbak, H. A., Hemeg, H. A., Chattopadhyay, A. P., & Afrin, F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s106548 · Cited by 80
Interventions for American cutaneous and mucocutaneous leishmaniasis
Pinart, M., Rueda, J.-R., Romero, G. A. S., Pinzón-Flórez, C. E., Osorio-Arango, K., Maia‐Elkhoury, A. N. S., Revéiz, L., Elias, V. M., & Tweed, J. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004834.pub3 · Cited by 80
Transcriptomic profiling of gene expression and RNA processing during Leishmania major differentiation
Dillon, L. A. L., Okrah, K., Hughitt, V. K., Suresh, R., Li, Y., Fernandes, M. C., Belew, A. T., Bravo, H. C., Mosser, D. M., & El-Sayed, N. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv656 · Cited by 80
High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
Diro, E., Lynen, L., Mohammed, R., Boelaert, M., Hailu, A., & van Griensven, J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002875 · Cited by 80
Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil
Valdivia, H. O., de Almeida, L. V., Roatt, B. M., Reis-Cunha, J. L., Pereira, A. A. S., Gontijo, C. M. F., Fujiwara, R. T., Reis, A. B., Sanders, M. J., Cotton, J. A., et al. (2017) · Scientific Reports · doi:10.1038/srep40804 · Cited by 79
Influences of climate change on the potential distribution of Lutzomyia longipalpis sensu lato (Psychodidae: Phlebotominae)
Peterson, A. T., Campbell, L. P., Moo-Llanes, D. A., Travi, B. L., González, C., Ferro, M. C., Ferreira, G. E. M., Brandão-Filho, S. P., Cupolillo, E., Ramsey, J. M., et al. (2017) · International Journal for Parasitology · doi:10.1016/j.ijpara.2017.04.007 · Cited by 79
Topical paromomycin for New World cutaneous leishmaniasis
Sosa, N. R., Pascale, J. M., Jiménez, A. I., Norwood, J. A., Kreishman-Deitrick, M., Weina, P. J., Lawrence, K. L., McCarthy, W. F., Adams, R. C., Scott, C., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007253 · Cited by 79
Leishmaniasis Beyond East Africa
Jones, C. M., & Welburn, S. C. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.618766 · Cited by 79
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds
Passalacqua, T. G., Dutra, L. A., de Almeida, L., Velásquez, Á. M. A., Torres, F. A. E., Yamasaki, P. R., dos Santos, M. B., Regasini, L. O., Michels, P. A. M., Bolzani, V. D. S., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.072 · Cited by 79
Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review
van Griensven, J., Gadisa, E., Aseffa, A., Hailu, A., Beshah, A. M., & Diro, E. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004495 · Cited by 79
Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review
Hashiguchi, Y., GOMEZ, E. A., Kato, H., Martini, L., Velez, L. N., & Uezato, H. (2016) · Tropical Medicine and Health · doi:10.1186/s41182-016-0002-0 · Cited by 79
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
Carnielli, J. B. T., Crouch, K., Forrester, S. J., Silva, V. C., de Carvalho, S. F. G., Damasceno, J. D., Brown, E. H., Dickens, N. J., Costa, D. L., Costa, C. H. N., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.029 · Cited by 79
Linalool loaded on glutathione-modified gold nanoparticles: a drug delivery system for a successful antimicrobial therapy
Jabir, M. S., Taha, A. A., & Sahib, U. I. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1457535 · Cited by 78
Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach
Kazemirad, E., Mohebali, M., Khadem‐Erfan, M. B., Saffari, M., Raoofian, R., Hajjaran, H., Hadighi, R., Khamesipour, A., Rezaie, S., Abedkhojasteh, H., et al. (2013) · Experimental Parasitology · doi:10.1016/j.exppara.2013.07.018 · Cited by 78
Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
Rai, K., Cuypers, B., Bhattarai, N. R., Uranw, S. K., Berg, M., Ostyn, B., Dujardin, J., Rijal, S., & Vanaerschot, M. (2013) · mBio · doi:10.1128/mbio.00611-13 · Cited by 78
2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro
Rodrigues, K. A. D. F., Dias, C. N. D. S., Andrade, P. N., Rocha, J. D. C., Scotti, L., Scotti, L., Rodrigues‐Mascarenhas, S., Veras, R. C., de Medeiros, I. A., Keesen, T. S. L., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.011 · Cited by 78
Lessons from other diseases: granulomatous inflammation in leishmaniasis
Kaye, P. M., & Beattie, L. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0548-7 · Cited by 78
Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis
Duarte, M. C., Pimenta, D. C., Menezes‐Souza, D., Magalhães, R. D. M., Diniz, J. L. C. P., Costa, L. E., Chávez‐Fumagalli, M. Á., Lage, P. S., Bartholomeu, D. C., Alves, M. J. M., et al. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00465-15 · Cited by 78
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
Rahman, R., Goyal, V., Haque, R., Jamil, K. M., Faiz, A., Samad, R., Ellis, S., Balasegaram, M., den Boer, M., Rijal, S., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005635 · Cited by 78

Authors: Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
Affiliations: World Health Organization (CH)
Universidad de Antioquia (CO)
Centers for Disease Control and Prevention (US)
Instituto de Salud Carlos III (ES)
Corresponding author: Alvar, Jorge
ORCID: Alvar, Jorge
Vélez, Iván D.
Bern, Caryn
Cano, Jorge
Boer, Margriet den
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2012-05-31
Volume: 7
Issue: 5
Pages: e35671
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0035671
PMC: PMC3365071
OpenAlex: W2107915297
Cited by: 5,141
References: 51
Citations by year: 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
FWCI: 310.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, public-domain)
Europe PMC (PubMed Central) (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Sanofi
Universidad de Medellín
Pan American Health Organization
Agencia Española de Cooperación Internacional para el Desarrollo
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
Keywords: leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
MeSH terms: Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks